Biological threats, ranging from natural outbreaks to adversary biotech advances, belong in the same readiness conversation, not in a separate public-health silo, as cyber and missile defense. Drawing on her experience running California's pandemic response and building PHC Global's AI-driven biothreat intelligence platform, Dr. Charity Dean believes that force protection, base readiness, and mission assurance in the Indo-Pacific require the same anticipatory intelligence architecture the U.S. has built for cyber and missile defense — applied to biological risk. She'll speak to what "left of boom" looks like for pathogens: real-time signal detection, AI-enabled early warning, and the interoperability gaps between DoW, HHS, and allied health systems that adversaries are positioned to exploit.